But there are tantalizing signs as the FDA prepares to review suvorexant that this drug may be fundamentally different from current sleeping pills like Ambien, Lunesta and Sonata, lacking their rare but troubling side effects, like memory loss and sleepwalking.
FORBES: Can A Safer Ambien Make Billions? Merck Aims To Find Out